• This topic is empty.
Viewing 0 reply threads
  • Author
    • #18654
      Jenny Livingston

      The CF community received some great news this week! Orkambi has been granted expanded use approval in the United States to treat children beginning at 12 months of age.

      “Today’s approval is another important step on our journey to reach people of all ages living with cystic fibrosis who may benefit from our medicines,” — Carmen Bozic, MD, and chief medical officer at Vertex

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account